期刊文献+

胰岛素样生长因子1和胰岛素抵抗与老年男性下尿路症状的相关性研究 被引量:2

Correlations of insulin-like growth factor-1 and insulin resistance with lower urinary tract symptoms in elderly male patients
原文传递
导出
摘要 目的研究血清胰岛素样生长因子1(IGF-I)、胰岛素抵抗与老年男性下尿路症状(LUTS)的相关性。方法选取2012年12月至2013年8月我院就诊的患有良性前列腺增生(BPH)患者96例,根据患者的LUTS、国际前列腺症状评分(IPSS)及经腹超声前列腺体积测定分为观察组54例:有较明显的LUTS且经IPSS评分为中重度症状;对照组42例:无明显LUTS或经IPSS评分仅为轻度症状。比较、分析两组间的一般资料和生化指标及其相关性。结果观察组和对照组空腹血糖分别为(6.3±0.7)mmol/L比(4.9±0.5)mmol/L、空腹胰岛素(11.9±3.1)mU/L比(8.0±2.O)mU/L、胰岛素抵抗指数(3.5±1.3)比(1.8±0.5)、低密度脂蛋白胆固醇(3.9±0.3)mmol/L比(2.2±0.4)mmol/L、前列腺体积(38.9±6.4)ml比(23.2±1.3)ml,差异有统计学意义(P〈0.05或P〈O.01);IGF-I为(114.6±25.6)μg/L比(165.3±48.6)μg/L、高密度脂蛋白胆固醇(1.1±0.3)mmol/L比(1.9±0.2)mmol/L,低于对照组(P〈0.01)。血清IGF-I水平与年龄、空腹血糖、空腹胰岛素、胰岛素抵抗指数及低密度脂蛋白胆固醇水平呈负相关(P〈0.05);前列腺体积与年龄、空腹血糖、空腹胰岛素和胰岛素抵抗指数呈正相关(P〈0.05),与高密度脂蛋白胆固醇水平呈负相关(P〈O.01)。结论血清IGF-I水平、胰岛素抵抗与BPH的程度有关,可能参与了BPH的发生、发展。 Objective To investigate the correlations of serum insulin-like growth factor-1 (IGF-I) and insulin resistance with lower urinary tract symptoms (LUTS) in elderly male patients. Methods 96 old-elderly patients with benign prostatic hyperplasia (BPH) were divided into two groups according to international prostate symptoms score (IPSS) and abdominal ultrasound- measured prostate volume: experimental group(n: 54, patients with obvious LUTS and IPSS score- assessed severe symptoms) and control group(n= 42, patients without obvious LUTS and slight symptoms assessed by IPSS scores). Clinical data and biochemical characteristics were compared between the two groups. The correlations between the indicators were analyzed. Results There were significant differences in levels of fasting blood glucose and fasting serum insulin, homeostasis model assessment- insulin resistance, low-density lipoprotein level, prostate volume between experimental and control groups [(6.3±0. 7) mmol/L vs (4.94±0. 5) mmol/L, (11.9±3. 1) mU/L vs (8.0±2.0) mU/L, (3.5±1.3) vs (1.8±0.5) , (3.9±0.3) mmol/L vs (2.2±0.4) mmol/L and (38.9±6.4) ml w (23.2± 1.3) ml, all P〈0.05, respectively). Serum levels of IGF-I and high-density lipoprotein cholesterol were lower in experimental than in control group [(114.6 ± 25.6) μg/Lvs (165.3 ± 48.6)μg/L) and (1.1±0.3) mmol/L vs (1.9±0.2) mmol/L, both P(0.01, respectively). The serum IGF-I level was negatively correlated with age, levels of fasting blood glucose, and fastingserum insulin, homeostasis model assessment- insulin resistance and low-density lipoprotein level (all P〈0.05). The prostate volume was positively correlated with age, levels of fasting blood glucose, fasting serum insulin, and homeostasis model assessment - insulin resistance (all P〈0.05), while negatively correlated with high-density lipoprotein cholesterol level (P^0.01). Conclusions The level of serum IGF-I and insulin resistance have a relation with BPH severity and might participate in the development of BPH.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2015年第2期147-149,共3页 Chinese Journal of Geriatrics
基金 河南省医学科技攻关项目(卫科2013-14201303217)
关键词 胰岛素样生长因子1 良性前列腺增生 排尿困难 Insulin-like growth factor-l Prostatic hyperplasia Dysuria
  • 相关文献

参考文献12

  • 1刘颖,屈晓冰,孟宪琴,胡志高,赵晓昆,沈芳,董莉妮.代谢综合征对老年人良性前列腺增生病程的影响[J].中华老年医学杂志,2011,30(11):909-913. 被引量:5
  • 2刘颖,屈晓冰,董莉妮,沈芳.老年人良性前列腺增生症与胰岛素抵抗[J].中华老年医学杂志,2010,29(11):896-898. 被引量:12
  • 3Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia F J-1. Clin Endocrinol Metas, 2006,91 : 2562-2568.
  • 4Nandeesha, H, Koher BC, Dorairajan LN, et al. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia E J 7 . Clinica Chimica Acta, 2006,370 : 89-93.
  • 5Hammarsten J, Hogstedt, B. Hyperinsulinaemia as a risk factor for developing Benign prostatic hyperplasia [J]. Eur Urol,2001,39.. 151-158.
  • 6Ozden C,Ozdal OL, Urgancioglu C, et al. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia [J]. European Urology, 2007,51 : 199-206.
  • 7Vikram A,Jena GB, Ramarao P. Increased ceil proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia[J]. Prostate, 2010,70:79-89.
  • 8Moses AC. Insulin resistance and type 2 diabetes mellitus: is there a therapeutic role for IGF-I[J]? Endocr Dev,2005,9 : 121-134.
  • 9Vikram A, Jena GB, Ramarao P. Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia[J]. Prostate, 2010,70 : 79-89.
  • 10DR, Moses AC, McKay MJ, et al. The combination of insulin-growth factor-1 and insulin-like growth factor binding protein-3 reduces insulin requirements and insulin-dependenttype 1 diabetes: evidence for in vivobiologica activity[J]. Clin Endocrinol Metab, 2000,85 1518-1524.

二级参考文献16

  • 1McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med, 2003, 349:2387-2398.
  • 2Eckel RH. Grundy SM, Zimmel PZ. The metabolic syndrome. Lancet,2005,365:1415-1428.
  • 3Whcatcroft SB, Williams IL, Shah AM, et al. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med, 2003,20: 255-268.
  • 4Berger AP, Bartsch G,Deibl M. Atherosclerosis as a risk factor for Benign Prostatic Hyperplasia. BJUInt, 2006,98:1038-1042.
  • 5张样华,王行耶,朱刚,等.良性前列腺增生诊断治疗指南.见:那彦群,主编.中国泌尿外科疾病诊断治疗指南(2007版).北京:人民卫生出版社,2007.167-204.
  • 6Lees S,Min H, Choi SH, et al. Central obesity as a risk factor for prostatic hyperplasia. Obesity, 2006, 14:172-179.
  • 7Parsons JK,Cater HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia. JCEM, 2006, 91~2562-2568.
  • 8Escobart EL, Gomes-marcondes MC, Carvalho HF. Dietary fatty acid quality afects AR and PPARgamma levels and prostate growth. Prostate,2009, 69:548-558.
  • 9Parsons JK, Bergstrom lipoperteins,and risk of in community dwelling 313-318. J, Hconnor E. Lipids, benign prostatic hyperplasia men. BJUI, 2008, 101..
  • 10Vikram A, Jena GB, Ramarao P. Increased cell proliferation and contractility of prostate in insulin resistant rats; linking hyperinsulinemia with benign prostate hvDerDlasia. Prostate, 2010, 70: 79-89.

共引文献13

同被引文献15

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部